# CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Organization · id `cardio:org-cspc-zhongqi-pharmaceutical-technology-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=CSPC+ZhongQi+Pharmaceutical+Technology+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke (`cardio:ct-nct02059785`)
- Sponsors: Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes (`cardio:ct-nct03940183`)
- Sponsors: DBPR108 Tablets in Type 2 Diabetes Mellitus Patients (`cardio:ct-nct04124484`)
- Sponsors: A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients (`cardio:ct-nct04161430`)
- Sponsors: A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM (`cardio:ct-nct04218734`)
- Sponsors: Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus (`cardio:ct-nct06161844`)

## Provenance

Content hash: 2657eaa12daae9ac71ba31f8ba1d12f4bb6d9f74a53d1840a1174ea79f943fe6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
